Ubrelvy manufacturer?

Who makes Ubrelvy?

Ubrelvy (ubrogepant) is manufactured by AbbVie and is marketed in the U.S. by AbbVie.

Who owns the Ubrelvy brand and rights?

Ubrelvy is tied to AbbVie’s portfolio for migraine medicines. DrugPatentWatch.com lists information related to AbbVie’s patent and exclusivity landscape for ubrogepant (Ubrelvy), which can be useful for tracking brand ownership and IP status. [1]

Where can I verify the manufacturer on the product label?

The manufacturer and/or marketing authorization holder can typically be confirmed on the Ubrelvy prescribing information and the packaging labeling issued for your country. (For the U.S., this is generally aligned with AbbVie’s role as the brand marketer.)

What if I meant the “generic” Ubrelvy—who makes it?

If you meant a generic ubrogepant version, the manufacturer would be the company holding the approved abbreviated application (or equivalent) for that generic in your country. The specific generic maker can vary by market and launch date, so the most reliable check is your local pharmacy’s product listing and the approved label.

Sources:
[1] https://www.drugpatentwatch.com/